|
gptkbp:instance_of
|
gptkb:musician
|
|
gptkbp:activities
|
drug release
|
|
gptkbp:approves
|
percutaneous coronary intervention
|
|
gptkbp:availability
|
gptkb:Europe
gptkb:Middle_East
gptkb:Asia
gptkb:Latin_America
gptkb:North_America
|
|
gptkbp:clinical_trial
|
gptkb:unstable_angina
gptkb:ISAR-TEST_trial
gptkb:SPIRIT_trial
stable angina
treatment of coronary artery disease
acute coronary syndrome
EXCEL trial
|
|
gptkbp:coat_of_arms
|
gptkb:everolimus
|
|
gptkbp:complications
|
gptkb:healthcare_organization
bleeding
stent thrombosis
in-stent restenosis
|
|
gptkbp:delivers
|
balloon catheter
|
|
gptkbp:diameter
|
2.5 mm
3.5 mm
4.0 mm
3.0 mm
|
|
gptkbp:events
|
imaging studies
regular check-ups
antiplatelet therapy
|
|
gptkbp:first_introduced
|
gptkb:2008
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Xience drug-eluting stent
|
|
gptkbp:length
|
28 mm
12 mm
18 mm
8 mm
15 mm
24 mm
|
|
gptkbp:manufacturer
|
gptkb:Abbott_Laboratories
|
|
gptkbp:marketed_as
|
gptkb:Xience_Alpine
gptkb:Xience_V
gptkb:Xience_Xpedition
|
|
gptkbp:regulatory_compliance
|
gptkb:CE_Mark
gptkb:FDA
|
|
gptkbp:research_focus
|
biocompatibility
drug delivery systems
long-term efficacy
stent design
|
|
gptkbp:treatment
|
improved patient outcomes
reduced restenosis rates
enhanced safety profile
lower rates of target lesion revascularization
|
|
gptkbp:type
|
stainless steel
|
|
gptkbp:bfsParent
|
gptkb:Abbott's_vascular_business_segment
|
|
gptkbp:bfsLayer
|
6
|